alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Federal Register: March 5, 2010 (Volume 75, Number 43)]
[Notices]               
[Page 10341]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05mr10-149]                         

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Office of the Secretary

 
Aviation Proceedings, Agreements Filed the Week Ending February 
13, 2010

    The following Agreements were filed with the Department of 
Transportation under the Sections 412 and 414 of the Federal Aviation 
Act, as amended (49 U.S.C. 1382 and 1384) and procedures governing 
proceedings to enforce these provisions. Answers may be filed within 21 
days after the filing of the application.

    Docket Number: DOT-OST-2010-0031.
    Date Filed: February 9, 2010.
    Parties: Members of the International Air Transport Association.
    Subject: Mail Vote 621.

Special Passenger Amending Resolution 010n, from Hong Kong SAR to 
India, (Memo 1355).
Intended effective date: 22 February 2010.

    Docket Number: DOT-OST-2010-0032.
    Date Filed: February 9, 2010.
    Parties: Members of the International Air Transport Association.
    Subject: Mail Vote 619.

TC3 Special Passenger Amending Resolution 010m between Korea (Rep. of) 
and China excluding Hong Kong SAR and Macao SAR, (Memo 1354).
Intended effective date: 15 February 2010.

    Docket Number: DOT-OST-2010-0033.
    Date Filed: February 12, 2010.
    Parties: Members of the International Air Transport Association.
    Subject: Mail Vote 622.

TC3 Within South East Asia, Special Passenger Amending Resolution 010o 
between Viet Nam and Myanmar (Memo 1356).
Intended effective date: 22 February 2010.

Renee V. Wright,
Program Manager, Docket Operations, Federal Register Liaison.
[FR Doc. 2010-4674 Filed 3-4-10; 8:45 am]
BILLING CODE 4910-9X-P
```
****

This chart presents 1997 Missouri exports to the Newly IndependentStates of the former Soviet Union.  Data used to create the chart werecollected by the Bureau of the Census, U.S. Department of Commerce,with further analysis by the University of Massachusetts,Massachusetts Institute for Social and Economic Research (MISER). Formore information call BISNIS at (202) 482-4655 or visit the MISER websiteat www.umass.edu/miser.
'96 export data for Missouri
'95 export data for Missouri
Return to USA Export Map
Return to BISNIS Home Page
#### § 93.205 Debarment or suspension.

*Debarment* or *suspension* means the Government wide exclusion, whether temporary or for a set term, of a person from eligibility for Federal grants, contracts, and cooperative agreements under the HHS regulations at 45 CFR part 76 (nonprocurement) and 48 CFR subparts 9.4 and 309.4 (procurement).
§ 488.865 Termination of provider agreement. ( a ) *Effect of termination by CMS.* Termination of the provider agreement ends— ( 1 ) Payment to the HHA; and
( 2 ) Any alternative sanction(s).
( b ) *Basis for termination.* CMS terminates an HHA's provider agreement under any one of the following conditions— ( 1 ) The HHA is not in compliance with the conditions of participation.
( 2 ) The HHA fails to submit an acceptable plan of correction within the timeframe specified by CMS.
( 3 ) The HHA fails to relinquish control to the temporary manager, if that sanction is imposed by CMS.
( 4 ) The HHA fails to meet the eligibility criteria for continuation of payment as set forth in § 488.860(a)(1).
( c ) *Notice.* CMS notifies the HHA and the public of the termination, in accordance with procedures set forth in § 489.53 of this chapter.
( d ) *Procedures for termination.* CMS terminates the provider agreement in accordance with procedures set forth in § 489.53 of this chapter.
( e ) *Appeal.* An HHA may appeal the termination of its provider agreement by CMS in accordance with part 498 of this chapter.
§ 493.1810 Imposition and lifting of alternative sanctions. ( a ) *Notice of noncompliance and of proposed sanction: Content.* If CMS or its agency identifies condition level noncompliance in a laboratory, CMS or its agent gives the laboratory written notice of the following: ( 1 ) The condition level noncompliance that it has identified.
( 2 ) The sanction or sanctions that CMS or its agent proposes to impose against the laboratory.
( 3 ) The rationale for the proposed sanction or sanctions.
( 4 ) The projected effective date and duration of the proposed sanction or sanctions.
( 5 ) The authority for the proposed sanction or sanctions.
( 6 ) The time allowed (at least 10 days) for the laboratory to respond to the notice.
( b ) *Opportunity to respond.* During the period specified in paragraph (a)(6) of this section, the laboratory may submit to CMS or its agent written evidence or other information against the imposition of the proposed sanction or sanctions.
( c ) *Notice of imposition of sanction* — ( 1 ) *Content.* CMS gives the laboratory written notice that acknowledges any evidence or information received from the laboratory and specifies the following: ( i ) The sanction or sanctions to be imposed against the laboratory.
( ii ) The authority and rationale for the imposing sanction or sanctions.
( iii ) The effective date and duration of sanction.
( 2 ) *Timing.* ( i ) If CMS or its agent determines that the deficiencies pose immediate jeopardy, CMS provides notice at least 5 days before the effective date of sanction.
( ii ) If CMS or its agent determines that the deficiencies do not pose immediate jeopardy, CMS provides notice at least 15 days before the effective date of the sanction.
( d ) *Duration of alternative sanctions.* An alternative sanction continues until the earlier of the following occurs: ( 1 ) The laboratory corrects all condition level deficiencies.
( 2 ) CMS's suspension, limitation, or revocation of the laboratory's CLIA certificate becomes effective.
( e ) *Lifting of alternative sanctions* — ( 1 ) *General rule.* Alternative sanctions are not lifted until a laboratory's compliance with all condition level requirements is verified.
( 2 ) *Credible allegation of compliance.* When a sanctioned laboratory submits a credible allegation of compliance, CMS's agent determines whether— ( i ) It can certify compliance on the basis of the evidence presented by the laboratory in its allegation; or
( ii ) It must revisit to verify whether the laboratory has, in fact, achieved compliance.
( 3 ) *Compliance achieved before the date of revisit.* If during a revisit, the laboratory presents credible evidence (as determined by CMS or its agent) that it achieved compliance before the date of revisit, sanctions are lifted as of that earlier date.
#### § 8.31 Authority and responsibilities of the reviewing official.

In addition to any other authority specified in this subpart, the reviewing official and the presiding official, with respect to those authorities involving the oral presentation, shall have the authority to issue orders; examine witnesses; take all steps necessary for the conduct of an orderly hearing; rule on requests and motions; grant extensions of time for good reasons; dismiss for failure to meet deadlines or other requirements; order the parties to submit relevant information or witnesses; remand a case for further action by the respondent; waive or modify the procedures in this subpart in a specific case, usually with notice to the parties; reconsider a decision of the reviewing official where a party promptly alleges a clear error of fact or law; and to take any other action necessary to resolve disputes in accordance with the objectives of the procedures in this subpart.
<PAGE>
                                                                    EXHIBIT 31.2

                                 CERTIFICATIONS



I, Michael L. DeMarco, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Peoples Educational
Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the small business
issuer as of, and for, the periods presented in this report;

4. The small business issuer's other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and
have:

a) designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the small business issuer, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

b) evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

c) Disclosed in this report any change in the small business issuer's internal
control over financial reporting that occurred during the small business
issuer's most recent fiscal quarter (the small business issuer's fourth fiscal
quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the small business issuer's internal
control over financial reporting; and

5. The small business issuer's other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the small business issuer's auditors and the audit committee of
small business issuer's board of directors (or persons performing the equivalent
functions):

a) all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.

Date: May 10, 2004

/s/ Michael L. DeMarco
----------------------
Michael L. DeMarco,
Chief Financial Officer
#### Ex parte Jacob Harold REACH. (Re: Jacob Harold REACH v. Jay Sena REACH).

78-857.

Supreme Court of Alabama.

Jan. 11, 1980.

*1119BEATTY, Justice.

WRIT DENIED.

BLOODWORTH, MADDOX, FAULKNER, JONES, SHORES and EMBRY, JJ:, concur.

TORBERT, C. J., and ALMON, J., dissent.
<PAGE>

                                                                    EXHIBIT 32.1

                         TEXTRON FINANCIAL CORPORATION

                           CERTIFICATION PURSUANT TO
                               RULE 13A-14(B) AND
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report of Textron Financial Corporation (the
"Company") on Form 10-K for the period ending January 3, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Ted R.
French, Chairman and Chief Executive Officer of the Company, certify, pursuant
to Rule 13a-14(b) and 18 U.S.C. sec. 1350, as adopted pursuant to sec. 906 of
the Sarbanes-Oxley Act of 2002, that:

          (1) the Report fully complies with the requirements of Section 13(a)
     or 15(d) of the Securities Exchange Act of 1934; and

          (2) the information contained in the Report fairly presents, in all
     material respects, the financial condition and results of operations of the
     Company.

                                          TEXTRON FINANCIAL CORPORATION

                                          /s/ TED R. FRENCH
                                          --------------------------------------
                                          Ted R. French
                                          Chairman and Chief Executive Officer

Date: February 26, 2004
<TABLE> <S> <C>

<ARTICLE>                       5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>               NOV-30-1995
<PERIOD-END>                    NOV-30-1995
<CASH>                          1,979,963
<SECURITIES>                    000
<RECEIVABLES>                   3,819,276
<ALLOWANCES>                    2,245,176
<INVENTORY>                     000
<CURRENT-ASSETS>                45,360
<PP&E>                          10,450,002
<DEPRECIATION>                  1,906,839
<TOTAL-ASSETS>                  21,818,486
<CURRENT-LIABILITIES>           894,192
<BONDS>                         000
<COMMON>                        000
<PREFERRED-MANDATORY>           000
<PREFERRED>                     000
<OTHER-SE>                      20,924,294
<TOTAL-LIABILITY-AND-EQUITY>    21,818,486
<SALES>                         2,431,302
<TOTAL-REVENUES>		3,375,107
<CGS>				000
<TOTAL-COSTS>                   1,375,079
<OTHER-EXPENSES>		511,476
<LOSS-PROVISION>		300,000
<INTEREST-EXPENSE>		000
<INCOME-PRETAX>                 1,188,552
<INCOME-TAX>                    000
<INCOME-CONTINUING>		1,188,552
<DISCONTINUED>                  000
<EXTRAORDINARY>                 000
<CHANGES>                       000
<NET-INCOME>                    1,188,552
<EPS-PRIMARY>                   11.55
<EPS-DILUTED>                   11.55
        		

</TABLE>
#### § 86.34 Evaluation and award of direct traineeships.

Within the limits of funds available for such purpose and subject to the regulations of this part, the Secretary may award direct traineeships to those qualified applicants who are in his judgment best able to carry out the purpose of the traineeships taking into consideration the need for training in the area of study specified in the application.
HomePeople...Charles O’Malley

# 				Charles O'Malley			

															Acting Dean, School of Applied Information Technology (SAIT)						Foreign Service Institute												

				July 19, 2021 -									August 8, 2021							

**Charles O’Malley's term ended on August 8, 2021.** Charles “Chuck” O’Malley joined the Department of State in July 1994 and has served at least one tour in every geographic bureau in the Department. These postings include Burundi, Singapore, India, Barbados, Vietnam, the United Kingdom, Washington, DC, Israel, and Turkey.Chuck is a graduate of the prestigious Foreign Service Institute (FSI) and Information Resource Management (IRM ) partnered Executive Development Program and holds a master’s degree in Government Information Leadership from the National Defense University. Chuck is known across the IRM community as a mentor and advisor and his annual career reference treatise is read by most in his field.
Tags
Foreign Service InstituteState Department OfficialBack to Top- White House
- USA.gov
- Office of the Inspector General
- Archives
- Contact Us
follow usFacebookXInstagramYouTubeFlickrGovDelivery- Privacy Policy
- Accessibility Statement
- Copyright Information
- FOIA
- No FEAR Act
U.S. Department *of* StateThe Lessons of 1989: Freedom and Our Future
###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.

#### § 11.100 [Reserved]
HomePlans, Performance, Budget...International Affairs Budgets

# 									International Affairs Budgets							

-  International Affairs Budgets-  														Fiscal Year 2025																											 
-  														Fiscal Year 2024																											 
-  														Fiscal Year 2023																											 
-  														Fiscal Year 2022																											 
 
-  International Affairs Budgets Archive: 2018-2021-  														Fiscal Year 2021																											 
-  														Fiscal Year 2020																											 
-  														Fiscal Year 2019																											 
-  														Fiscal Year 2018																											 
 
-  International Affairs Budgets Archive: 2010-2017-  														Fiscal Year 2017																											 
-  														Fiscal Year 2016																											 
-  														Fiscal Year 2015																											 
-  														Fiscal Year 2014																											 
-  														Fiscal Year 2013																											 
-  														Fiscal Year 2012																											 
-  														Fiscal Year 2011																											 
-  														Fiscal Year 2010																											 
 
-  International Affairs Budgets Archive: 2002-2009-  														Fiscal Year 2009																											 
-  														Fiscal Year 2008																											 
-  														Fiscal Year 2007																											 
-  														Fiscal Year 2006																											 
-  														Fiscal Year 2005																											 
-  														Fiscal Year 2004																											 
-  														Fiscal Year 2003																											 
-  														Fiscal Year 2002																											 
 

Back to Top
**Exhibit 31(b)****CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)**I, Thomas N. Tipton Jr., certify that: 1. I have reviewed this report on Form 10-Q of Interphase Corporation (the “Company”);  2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report;  3. Based on my knowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the Company as of, and for, the periods presented in this report;  4. The Company’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules13a-15(f) and 15d-15(f)) for the Company and have:(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe Company, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;(b) Designed such internal control over financial reporting, or caused such an internal controlover financial reporting to be designed under our supervision, to provide reasonable assuranceregarding the reliability of financial reporting and the preparation of financial statements forexternal purposes in accordance with generally accepted accounting principles;(c) Evaluated the effectiveness of the Company’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and(d) Disclosed in this report any change in the Company’s internal control over financialreporting that occurred during the Company’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, the Company’s internal control overfinancial reporting; and 5. The Company’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the Company’s auditors and theaudit committee of the Company’s board of directors:(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the Company’sability to record, process, summarize and report financial information; and(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the Company’s internal control over financial reporting.       Date: August 10, 2007 Signature: /s/ Thomas N. Tipton Jr.                  Chief Financial Officer
- Office Home
- Leadership
- Remarks and Releases
- Reports

HomeOffice of Diversity and Inclusion...Reports—Office of Diversity and Inclusion

# 									Reports							

Office of Diversity and Inclusion

-  Reports-  														DEIA Demographic Baseline Report																											 
-  														Diversity, Equity, Inclusion, and Accessibility Strategic Plan 2022 – 2026																											 
 

Back to Top
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.162 Applicant, oath or declaration.

The inventor named for a plant patent application must be the person who has invented or discovered and asexually reproduced the new and distinct variety of plant for which a patent is sought. The inventor's oath or declaration, in addition to the averments required by § 1.63 or § 1.64, must state that the inventor has asexually reproduced the plant. Where the plant is a newly found plant, the inventor's oath or declaration must also state that it was found in a cultivated area.

[77 FR 48821, Aug. 14, 2012]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.